Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, Nakahata T, Manabe A; Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group.
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.
Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J, Zhou XF, Zhao F, Zhou JF, Chen Y.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):111-6.
PMID:19236759
Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes.
Schouten HC, Delwel R, Bot FJ, Hagemeijer A, Touw IP, Löwenberg B.